Inactivation of N-Acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids

Biochemistry

Volumn 45, Issue 15, 2006, Pages 4720-4726

  Leung, Donmienne ^a   Saghatelian, Alan ^a   Simon, Gabriel M ^a   Cravatt, Benjamin F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; ENZYMES; GENES; LIPIDS; SIGNALING;

ENDOCANNABINOIDS; PHOSPHATIDYLETHANOLAMINE; SIGNALING LIPIDS;

AMINES;

ANANDAMIDE; CALCIUM; ENDOCANNABINOID; ETHANOLAMINE; FATTY ACID AMIDASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DEGRADATION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE DISRUPTION; LIPID BRAIN LEVEL; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BRAIN; ENDOCANNABINOIDS; ETHANOLAMINES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MODELS, GENETIC; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPASE D; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 33645935391     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi060163l     Document Type: Article

References (30)

1. Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutierrez, S. O., van der Stelt, M., Lopez-Rodriguez, M. L., Casanova, E., Schutz, G., Zieglgansberger, W., Di Marzo, V., Behl, C., and Lutz, B. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity, Science 302, 84-8.
2. Ishii, I., Fukushima, N., Ye, X., and Chun, J. (2004) Lysophospholipid receptors: signaling and biology, Annu. Rev. Biochem. 73, 321-54.
3. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science 258, 1946-9.
4. Lambert, D. M., Vandevoorde, S., Jonsson, K. O., and Fowler, C. J. (2002) The palmitoylethanolamide family: a new class of anti-inflammatory agents?, Curr. Med. Chem. 9, 663-74.
5. Rodriguez de Fonseca, F., Navarro, M., Gomez, R., Escuredo, L., Nava, F., Fu, J., Murillo-Rodriguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., Kathuria, S., Gall, C., and Piomelli, D. (2001) An anorexic lipid mediator regulated by feeding, Nature 414, 209-12.
6. Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., and Gilula, N. B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides, Nature 384, 83-7.
7. McKinney, M. K., and Cravatt, B. F. (2005) Structure and function of Fatty Acid amide hydrolase, Annu. Rev. Biochem. 74, 411-32.
8. Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., and Lichtman, A. H. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase, Proc. Natl. Acad. Sci. U.S.A. 98, 9371-6.
9. Lichtman, A. H., Shelton, C. C., Advani, T., and Cravatt, B. F. (2004) Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia, Pain 109, 319-27.
10. Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Walker, J. M., Holmes, P. V., Crystal, J. D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., and Piomelli, D. (2005) An endocannabinoid mechanism for stress-induced analgesia, Nature 435, 1108-12.
11. Lichtman, A. H., Leung, D., Shelton, C., Saghatelian, A., Hardouin, C., Boger, D., and Cravatt, B. F. (2004) Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity, J. Pharmacol. Exp. Ther. 311, 441-8.
12. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M., Palmery, M., Cuomo, V., and Piomelli, D. (2003) Modulation of anxiety through blockade of anandamide hydrolysis, Nat. Med. 9, 76-81.
13. Cravatt, B. F., Saghatelian, A., Hawkins, E. G., Clement, A. B., Bracey, M. H., and Lichtman, A. H. (2004) Functional disassociation of the central and peripheral fatty acid amide signaling systems, Proc. Natl. Acad. Sci. U.S.A. 101, 10821-6.
14. Holt, S., Comelli, F., Costa, B., and Fowler, C. J. (2005) Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors, Br. J. Pharmacol. 146, 467-76.
15. Schmid, H. H. (2000) Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?, Chem. Phys. Lipids 108, 71-87.
16. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., and Ueda, N. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners, J. Biol. Chem. 279, 5298-305.
17. Ueda, N., Liu, Q., and Yamanaka, K. (2001) Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations, Biochim. Biophys. Acta 1532, 121-7.
18. Clement, A. B., Hawkins, E. G., Lichtman, A. H., and Cravatt, B. F. (2003) Increased seizure susceptibility and pro-convulsant activity of anandamide in mice lacking fatty acid amide hydrolase, J. Neurosci. 23, 3916-23.
19. Saghatelian, A., Trauger, S. A., Want, E. J., Hawkins, E. G., Siuzdak, G., and Cravatt, B. F. (2004) Assignment of endogenous substrates to enzymes by global metabolite profiling, Biochemistry 43, 14332-9.
20. Daiyasu, H., Osaka, K., Ishino, Y., and Toh, H. (2001) Expansion of the zinc metallo-hydrolase family of the beta-lactamase fold, FEBS Lett. 503, 1-6.
21. Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G., and Piomelli, D. (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoylbiphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation, J. Pharmacol. Exp. Ther. 313, 352-8.
22. Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., and Sanudo-Pena, M. C. (1999) Pain modulation by release of the endogenous cannabinoid anandamide, Proc. Natl. Acad. Sci. U.S.A. 96, 12198-203.
23. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., and Piomelli, D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons, Nature 372, 686-91.
24. Cadas, H., Gaillet, S., Beltramo, M., Venance, L., and Piomelli, D. (1996) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP, J. Neurosci. 16, 3934-42.
25. Okamoto, Y., Morishita, J., Wang, J., Schmid, P. C., Krebsbach, R. J., Schmid, H. H., and Ueda, N. (2005) Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines, Biochem. J. 389, 241-7.
26. Guo, Y., Wang, H., Okamoto, Y., Ueda, N., Kingsley, P. J., Marnett, L. J., Schmid, H. H., Das, S. K., and Dey, S. K. (2005) N- acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation, J. Biol. Chem. 280, 23429-32.
27. Merkel, O., Schmid, P. C., Paltauf, F., and Schmid, H. H. (2005) Presence and potential signaling function of N-acylethanolamines and their phospholipid precursors in the yeast Saccharomyces cerevisiae, Biochim. Biophys. Acta 1734, 215-9.
28. Liu, J., Wang, L., Harvey-White, J., and Kunos, G. (2005) ICRS 2005 Symposium Abstract 119.
29. Patricelli, M. P., and Cravatt, B. F. (2001) Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides, Vitam. Horm. 62, 95-131.
30. Fernandez, J. R., and Allison, D. B. (2004) Rimonabant Sanofi-Synthelabo, Curr. Opin. Invest. Drugs 5, 430-5.